Granules India Limited has strengthened its research and development ecosystem by inaugurating two state-of-the-art Centres of Excellence at the Technology Research Park of IIT Hyderabad. The announcement was made on Monday, December 1, 2025, through an exchange filing.
The centres—Ascelis Center of Excellence for Peptide Development and Characterization and the Granules Center of Excellence for Particle Engineering—were inaugurated by Dr. Krishna Prasad Chigurupati, Chairman & Managing Director of Granules India, along with senior leadership from the company and IIT Hyderabad.
Peptide development facility to strengthen CDMO pipeline
The Ascelis Center of Excellence, built under the company’s CDMO arm Ascelis Peptides, will focus on developing cosmetic, therapeutic, and pharmaceutical peptides. Equipped for primary, secondary, and tertiary structure characterization, the centre is expected to significantly reduce reliance on external partners and work closely with Granules’ Swiss-based unit Senn Chemicals.
Particle engineering centre to drive novel drug delivery innovation
The second facility, the Granules Center of Excellence for Particle Engineering, will support research in polymorph development, material science, and innovative drug-delivery systems such as amorphous solid dispersions. This dedicated platform replaces earlier ad-hoc development and is expected to enhance formulation performance and enable first-to-file opportunities globally.
Dr. Chigurupati said the new facilities mark a major step toward building advanced scientific capabilities:
“Scientific excellence and rigorous research have always shaped our long-term strategy. These Centres of Excellence significantly strengthen our capabilities in peptides and advanced material sciences, areas that will define the next wave of pharmaceutical innovation.”
About the company
Granules India, founded in 1991, is a vertically integrated pharmaceutical player involved across the value chain—from APIs and PFIs to finished dosages and peptide CDMO solutions—with a presence in over 80 countries and 11 manufacturing facilities worldwide.
